BUTOFILOLOL

Butofilolol is a beta‑blocker reducing blood pressure and cardiac workload. Side effects include fatigue, dizziness, and cold extremities.

SKU: 0908952ffe9d Category: Tag:

Product Description


Mechanism of action

Butofilolol is a non-selective β-adrenergic receptor antagonist exhibiting partial agonist (ISA) properties. It binds to β₁ and β₂ receptors, decreasing heart rate, myocardial oxygen demand and contractility while exerting mild intrinsic β stimulation in resting states, reducing bradycardia risk compared to pure antagonists.

Benefits and advantages

Used in cardiovascular-receptor studies, β-receptor selectivity modelling, adrenergic signalling research, arrhythmia models and comparisons of ISA vs non-ISA beta-blockers in functional assays.

Side effects and risks

Risks include bronchoconstriction, fatigue, dizziness, bradycardia, hypotension and masking of hypoglycaemia. Handle using beta-blocker safety protocols.

Datasheet


Molecular Formula

C17H26FNO3

Molecular Weight

311.4 g/mol

CAS Number

58930-32-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Butofilolol; 58930-32-8; 64552-17-6; 4AZC6Y5A8G; CM-6805

IUPAC/Chemical Name

1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one

InChl Key

NMBNQRJDEPOXCP-UHFFFAOYSA-N

InChl Code

InChI=1S/C17H26FNO3/c1-5-6-15(21)14-9-12(18)7-8-16(14)22-11-13(20)10-19-17(2,3)4/h7-9,13,19-20H,5-6,10-11H2,1-4H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/68838;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download